Literature DB >> 35573549

Monoradiculopathy Caused by Sporadic Hemangioblastoma of the Conus Medullaris: Case Report and Literature Review.

Ivo Kehayov1, Polina Angelova1, Ivan Batakliev1, Veselin Belovezhdov2, Borislav Kitov3.   

Abstract

Sporadic spinal extramedullary hemangioblastomas of the conus medullaris are extremely rare. We present the case of a 40-year-old male with symptoms of severe back pain and monoradiculopathy. The magnetic resonance imaging (MRI) revealed an intradural extramedullary tumor attached to the conus medullaris. Total tumor removal was achieved via a typical posterior midline approach through laminectomy of L1 and L2 vertebrae, resulting in complete resolution of the preoperative symptoms. The histological examination was consistent with hemangioblastoma. To the best of our knowledge, this is the fifth case reported in the literature. We performed a brief literature review outlining the mainstay of diagnosis and therapeutic approach to these challenging lesions.
Copyright © 2022, Kehayov et al.

Entities:  

Keywords:  conus medullaris; hemangioblastoma; intradural extramedullary; spinal; surgery

Year:  2022        PMID: 35573549      PMCID: PMC9100991          DOI: 10.7759/cureus.24099

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Hemangioblastomas represent 1-3% of all central nervous system tumors and are most frequently located in the cerebellum, brain stem, and spinal cord [1]. Most spinal hemangioblastomas are located in the cervical and thoracic areas but can also be found at the level of filum terminale and cauda equina, while conus medullaris localization is extremely rare [2-4]. Hemangioblastoma can be sporadic or associated with the von Hippel-Lindau syndrome with autosomal dominant inheritance caused by the VHL gene mutation in 3p25-26 chromosomes. The syndrome is also linked with other types of tumors such as retinal angiomatosis, endolymphatic sac neoplasms, kidney or pancreatic cancer, pheochromocytoma, etc. [5]. We present a case of sporadic hemangioblastoma in the area of the conus medullaris and cauda equina. We also conducted a brief literature review of the diagnostic and treatment approaches for this rare tumor location. To the best of our knowledge, this is the fifth reported case in the literature.

Case presentation

We present the case of a 40-year-old male patient who presented with a gradual onset of progressive severe back pain for a duration of four months prior to hospital admission. The pain radiated towards the upper anterior surface of the right thigh. The symptoms were not relieved by conservative treatment with non-steroid anti-inflammatory drugs and were misinterpreted as a degenerative spinal disease. At hospital admission, the neurological examination revealed severe back pain, hyperalgesia, and hyperesthesia along the right L2 dermatome. The magnetic resonance imaging (MRI) revealed an intradural extramedullary tumor at the L1-L2 level, tightly adherent to the conus medullaris cranially and displacing the filum terminale and cauda equina roots to the right (Figure 1A-1C).
Figure 1

Imaging and histological diagnosis

(A-C) Sagittal Т1-weighted, T2-weighted and turbo inversion recovery magnitude (TIRM) MRI images showing well-circumscribed intradural extramedullary neoplasm, measuring 4.5 cm × 1 cm, adherent to conus medullaris (arrows); (D) histological examination demonstrating tumor rich in stromal cells with small nuclei, large vacuoles, scattered red blood cells, thin-walled vessels and microhemorrhages (HE × 100); (E) postoperative sagittal T2-weighted MRI demonstrating total tumor removal.

Imaging and histological diagnosis

(A-C) Sagittal Т1-weighted, T2-weighted and turbo inversion recovery magnitude (TIRM) MRI images showing well-circumscribed intradural extramedullary neoplasm, measuring 4.5 cm × 1 cm, adherent to conus medullaris (arrows); (D) histological examination demonstrating tumor rich in stromal cells with small nuclei, large vacuoles, scattered red blood cells, thin-walled vessels and microhemorrhages (HE × 100); (E) postoperative sagittal T2-weighted MRI demonstrating total tumor removal. The patient was operated on via typical midline posterior surgical access through laminectomy of L1 and L2 vertebrae. The dura mater was found to be tense. After midline durotomy and arachnoid incision, we evacuated xanthochromatous cerebrospinal fluid. A cherry-red intradural extramedullary tumor with a subtle capsule was visualized that originated from the area of the conus medullaris and ventrally displaced the filum terminale. The surrounding roots of the cauda equina as well as the caudal and cranial poles of the tumor were identified (Figure 2A). Using a careful microsurgical technique in a step-by-step fashion, we first dissected the caudal pole of the tumor and relatively easily freed it from the surrounding nerve roots and filum terminale, which all remained intact. Only the cranial pole of the tumor necessitated meticulous separation due to its tight adherence to the conus medullaris. Finally, the tumor was totally removed en-bloc (Figure 2B).
Figure 2

Intraoperative images

(A) Tumor measuring 4.5 cm × 1 cm with fine capsule, originating from conus medullaris (white arrow) dislocating laterally the roots of cauda equina (black-and-white arrows); (B) magnified view after total tumor removal.

Intraoperative images

(A) Tumor measuring 4.5 cm × 1 cm with fine capsule, originating from conus medullaris (white arrow) dislocating laterally the roots of cauda equina (black-and-white arrows); (B) magnified view after total tumor removal. The postoperative period was uneventful, with complete resolution of the preoperative symptoms. The histological examination revealed a tumor formation rich in stromal cells with small nuclei, large vacuoles, scattered red blood cells, and thin-walled vessels and microhemorrhages consistent with hemangioblastoma (Figure 1D). Given the histological findings, ophthalmoscopy, abdominal ultrasound, head and whole spine MRI were performed. No lesions typical of von Hippel-Lindau syndrome were found. The six-month follow-up confirmed normal neurological status and total tumor removal on the postoperative MRI (Figure 1E).

Discussion

Sporadic intradural extramedullary hemangioblastomas of the conus medullaris are extremely rare, with only four cases reported in the literature worldwide (Table 1) [1,4,6,7].
Table 1

Overview of published cases with sporadic intradural extramedullary hemangioblastomas of the conus medullaris

AuthorsAgeGenderClinical presentationvon Hippel-Lindau syndromeTotal resection of tumorComplete recovery
Brisman et al. [6]57FLumbalgia and right leg radiculopathyNoYesYes
Dinc et al. [7]33FLumbalgia and right leg radiculopathyNoYesYes
Welling et al. [4]43МLumbalgia and legs dysesthesiaNoYesYes
Shields et al. [1]65МLumbalgia and leg paresthesiaNoYesYes
Our case40МLumbalgia and right leg radiculopathyNoYesYes
The age of the patients varied from 33 to 57 years, and our patient is no exception. Including the current case, the percentage of male patients prevails slightly, nearing 60%. Like others, our patient presented with pronounced lumbalgia, pain, and radiculopathy (Table 1). In all five cases, total tumor removal and complete postoperative recovery were achieved, which led to a definitive cure (Table 1). Small-sized spinal cord hemangioblastomas in the area of the conus medullaris and cauda equina are usually asymptomatic. The neurological deficit occurs gradually with the increase in tumor size [1]. The most common symptoms are lumbalgia and radiculopathy, with hyperalgesia and dysesthesia radiating towards the legs. Myelopathy may occur with significant tumor growth associated with spinal cord and conus medullaris compromise [5]. Non-contrast and contrast-enhanced MRI are the gold standards for diagnosing hemangioblastomas [8]. In the T1 sequence, the tumor appears isointense, while in T2 it is moderately heterogeneous compared to the spinal cord. Generally, gadolinium application leads to intense enhancement of the tumor mass [8]. Sporadic intradural extramedullary hemangioblastomas are usually amenable to total surgical removal. In such cases, complete patient recovery is observed in over 96% of the cases [5]. Recurrence rates are higher in subtotal tumor resections or in tumors associated with von Hippel-Lindau syndrome [5]. The diagnosis of spinal hemangioblastomas is difficult due to overlapping symptoms with degenerative spinal diseases as well as the variety of neoplasms and vascular malformations (arteriovenous malformations, dural arteriovenous fistula, and cavernous malformation) that share similar MRI characteristics [1]. The neuroimaging differential diagnosis of an intradural extramedullary tumor in the area of conus medullaris and cauda equina includes a broad variety of spinal intradural lesions, such as nerve sheath tumors (schwannoma or neurofibroma), meningioma, paraganglioma, myxopapillary ependymoma, metastasis, and hemangioblastoma [9,10]. In contrast to intradural metastases, which are usually multiple, the rest of the neoplasms have similar neuroimaging findings and require further differentiation [8] (Table 2).
Table 2

Differential diagnosis of spinal hemangioblastomas and other spinal lesions based on their MRI characteristics

Differential diagnosis of spinal hemangioblastomaT1 MRIT2 MRIT1 C+ (Gd) MRI
Spinal hemangioblastomaHypo- to isointenseIso- to hyperintense; surrounding edema; associated syrinxVivid enhancement
Spinal meningiomaIsointense to slightly hypointenseIsointense to slightly hyperintenseModerate homogeneous enhancement
Mixopapillary epedymomaIsointenseOverall high intensityEnhancement is virtually always seen
Leptomeningeal spinal metastasesIsointense thickened nerve roots or nodular lesionsSpinal cord edemaEnhancing tumor nodules on the spinal cord, nerve roots or cauda equina;
Spinal schwannoma75% are isointense, 25% are hypointenseHyperintense, often with mixed signalEnhancement is virtually always seen
Spinal neurofibromaHypointenseHyperintenseHeterogenous enhancement
Spinal paragangliomaIsointenseHyperintenseEnhancement is virtually always seen
Spinal cord metastasesHypointenseHyperintenseAvid enhancement in >80% of cases
Spinal astrocytomaIsointense to hypointenseHyperintenseVast majority enhance; patchy enhancement pattern
Spinal ependymomaIsointense to hypointenseHyperintenseEnhance strongly, somewhat inhomogeneously
Spinal arteriovenous malformationsSignal voids from high-velocity flow; dilated perimedullary vesselsSignal voids from high-velocity flow; increased cord signalN/A
Spinal dural arteriovenous fistulaIntramedullary hypointensity and flow voids on the cord surfaceDiffuse multilevel intramedullary hyperintensity (edema); hypointensity in the periphery of the cord; prominent serpiginous intradural extramedullary flow voids - most specific findingPatchy intramedullary enhancement; serpentine enhancing veins on the cord surface
Spinal cavernous malformationRounded regions of heterogeneous signal intensityRounded regions of heterogeneous signal intensity; low signal intensity rimMinimal enhancement
The preoperative differentiation of spinal tumors from vascular abnormalities is of particular importance. In such cases, selective spinal angiography is a useful tool for the diagnosis of suspected vascular malformations. It can also be used to perform preoperative embolization, which reduces intraoperative bleeding [7,11]. In our case, we present the difficulties in the differential diagnosis of sporadic intradural extramedullary hemangioblastoma of the conus medullaris. In the same way as the case described by Shields et al., the suggested preoperative MRI diagnosis was ependymoma or schwannoma [1], while the final histological examination revealed hemangioblastoma.

Conclusions

The differential diagnosis of tumors in the area of conus medullaris and/or cauda equina should include hemangioblastomas. Selective spinal angiography could facilitate the differentiation between spinal tumors and vascular pathology. In cases with proven spinal hemangioblastomas, a screening for von Hippel-Lindau syndrome should be performed. MRI is the imaging method of choice for accurate preoperative topical diagnosis and adequate surgical planning. The aim of the surgery must be total tumor removal, which provides permanent neurological recovery for these patients and reduces recurrence rates.
  7 in total

Review 1.  Primary Intradural Extramedullary Sporadic Spinal Hemangioblastomas: CASE Report and Systematic Review.

Authors:  Daphne Li; Shawn Choe; Ewa Borys; Joseph C Serrone; Anand V Germanwala
Journal:  World Neurosurg       Date:  2021-06-01       Impact factor: 2.104

Review 2.  Extramedullary hemangioblastoma of the conus medullaris.

Authors:  J L Brisman; L F Borges; C S Ogilvy
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

3.  Conus medullaris and cauda equina tumors: clinical presentation, prognosis, and outcome after surgical treatment: clinical article.

Authors:  Maria Wostrack; Ehab Shiban; Thomas Obermueller; Jens Gempt; Bernhard Meyer; Florian Ringel
Journal:  J Neurosurg Spine       Date:  2014-01-17

Review 4.  Hemangioblastoma of the filum terminale associated with von Hippel-Lindau disease: a case report.

Authors:  Bulent Tucer; Mehmet Ali Ekici; Burak Kazanci; Bulent Guclu
Journal:  Turk Neurosurg       Date:  2013       Impact factor: 1.003

Review 5.  Spinal hemangioblastoma: surgical procedures, outcomes and review of the literature.

Authors:  Huanyu Wang; Liping Zhang; Hong Wang; Yang Nan; Quanfeng Ma
Journal:  Acta Neurol Belg       Date:  2020-07-07       Impact factor: 2.396

6.  Sporadic hemangioblastoma of the film terminale with peritumoral cyst.

Authors:  Miho Zaimoku; Yoshiharu Kawaguchi; Shoji Seki; Yasuhito Yahara; Naoki Akioka; Johji Imura; Tomoatsu Kimura; Satoshi Kuroda
Journal:  Surg Neurol Int       Date:  2018-01-10

7.  Sporadic hemangioblastoma of cauda equina: An atypical case report.

Authors:  Henrique Oliveira Martins; Roger Schmidt Brock; Mario Augusto Taricco; José Francisco Pereira Júnior; Matheus Fernandes de Oliveira
Journal:  Surg Neurol Int       Date:  2019-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.